We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TWFG:NASDAQTWFG, Inc. Analysis

Data as of 2026-06-22 - not real-time

$21.67

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

TWFG is trading at $21.67, comfortably above its 20‑day (≈$19.96) and 50‑day (≈$19.36) simple moving averages, while still sitting below the 200‑day average of $23.33, indicating a short‑term bullish bias within a longer‑term neutral framework. Technical momentum is reinforced by a bullish MACD histogram (+$0.19) and an RSI of 62.6, suggesting the stock has upward thrust but is approaching overbought territory. The share price reflects a high implied volatility of over 43% on a 30‑day basis, yet the beta of –0.22 points to a low correlation with broader market moves, offering a potential defensive edge.
Fundamentally, TWFG posted a 35% revenue surge to $267.5 M, maintains an impressive 85% gross margin and a 16.9% operating margin, and generates $60.6 M of operating cash flow against modest debt of $8.5 M. Despite a trailing P/E of 38.7—well above the industry average of 16.9—the forward P/E contracts to 19.6, and a DCF‑derived fair value of $126.4 suggests substantial upside, albeit with a modest 8.8% upside/downside estimate. The company’s participation in the William Blair Growth Stock Conference underscores growing investor interest, while the absence of a dividend confirms a reinvest‑focused growth strategy.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above short‑term SMAs and bullish MACD
  • High 30‑day volatility and approaching overbought RSI
  • Low beta reducing market‑wide downside exposure

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong 35% revenue growth and high gross margin
  • Forward P/E compression and DCF upside potential
  • Increased visibility from conference presentation

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Durable insurance brokerage model with diversified product suite
  • Robust operating cash flow and minimal debt load
  • Undervalued relative to growth prospects despite high trailing multiples

Key Metrics & Analysis

Financial Health

Revenue Growth35.30%
Profit Margin3.13%
P/E Ratio38.7
ROE16.16%
ROA7.77%
Debt/Equity2.78
P/B Ratio4.4
Op. Cash Flow$60.6M
Free Cash Flow$-42008500
Industry P/E16.9

Technical Analysis

TrendNeutral
RSI62.6
Support$17.90
Resistance$22.25
MA 20$19.96
MA 50$19.36
MA 200$23.33
MACDBullish
VolumeStable
Fear & Greed Index91.14

Valuation

Fair Value$126.43
Target Price$23.57
Upside/Downside8.77%
GradeFair
TypeBlend

Risk Assessment

Beta-0.22
Volatility43.13%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.